 |  |  |  |  |  |  |  |  |
Below you'll find a list of all posts that have been tagged as “Silvec Biologics”
Texas A&M AgriLife Research scientists led by Kranthi Mandadi are seeking novel solutions to huanglongbing (HLB), also known as citrus greening disease. Mandadi is a professor in the Texas A&M Department of Plant Pathology and Microbiology and a researcher at the Texas A&M AgriLife Research and Extension Center at Weslaco. In the past few years, he and his collaborators have …
Silvec Biologics announced that an RNA vector delivery product to combat HLB has progressed to the Full Science Review Phase of the Environmental Protection Agency (EPA) Pesticide Regulation Improvement Act registration process. The product was developed in collaboration with Southern Gardens Citrus (a subsidiary of U. S. Sugar), the University of Florida (UF) and Texas A&M AgriLife Research. Silvec is …
Australia’s Hort Innovation has announced an $8.7 million investment to trial tree immunizations that protect Australia’s horticulture industries against the deadly huanglongbing (HLB) and Xylella diseases (including citrus variegated chlorosis). Hort Innovation is a grower-owned, not-for-profit research and development corporation for Australia’s horticulture industry. Hort Innovation Chief Executive Brett Fifield said the investment aims to safeguard key Australian horticulture industries by …
